Medulloblastoma natural history
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Syed Musadiq Ali M.B.B.S.[2]Haytham Allaham, M.D. [3]
Overview
Overview
If left untreated, patients with medulloblastoma may progress to develop ataxia, nystagmus, and positional dizziness. Common complications of medulloblastoma include hydrocephalus, decerebrate attacks, and cranial nerve palsies. Prognosis is generally good, the 5-year survival rate of patients with medulloblastoma is approximately 69%.[1]
Natural History
Natural History
Complications
Complications
- Common complications of medulloblastoma include:[1]
- Increased intracranial pressure
- Third, fourth, and sixth cranial nerve palsy
- Decerebrate attacks
Prognosis
Prognosis
- Medulloblastoma prognosis is generally good.
- The 5-year survival rate of patients with medulloblastoma is approximately 69%.[1]
- The 10-year survival rate of patients with medulloblastoma is approximately 52%.
- Younger age in children is associated with worse prognosis.[2]
- The prognosis varies with the molecular subgroup of medulloblastoma, such as:[1]
- Medulloblastoma WNT molecular subgroup is associated with the most favorable prognosis.
- Medulloblastoma Group 4 and SHH molecular subgroups are associated with an intermediate prognosis.
- Medulloblastoma Group 3 molecular subgroup is associated with a poor prognosis.
References
References
- ↑ 1.0 1.1 1.2 1.3 1.4 Medulloblastoma. Wikipedia(2015) https://en.wikipedia.org/wiki/Medulloblastoma Accessed on September 25, 2015
- ↑ Saran FH, Driever PH, Thilmann C, Mose S, Wilson P, Sharpe G; et al. (1998). “Survival of very young children with medulloblastoma (primitive neuroectodermal tumor of the posterior fossa) treated with craniospinal irradiation”. Int J Radiat Oncol Biol Phys. 42 (5): 959–67. PMID 9869216.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
